Biotechnology News

April 30, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS.OB) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, was honored to be the Sponsor and an Exhibitor at the 7th national...

April 30, 2012

CONCORD, Calif. & BERN, Switzerland & GENEVA--(BUSINESS WIRE)--Cerus, the University Hospitals of Geneva and the Swiss Red Cross Transfusion Service intend to collaborate on adapting the Cerus INTERCEPT red cell system to improve blood...

April 30, 2012

NEW YORK--(BUSINESS WIRE)--TKL Research, a clinical research organization (CRO), has selected Medidata CTMS as part of an initiative to expand its clinical trial operations.

April 30, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (TEVA), one of the world’s largest producers of pharmaceuticals, announces that it has settled patent infringement litigation regarding U.S. Patent Number 7,132,570 (the "'570 patent...

April 30, 2012

NEW YORK--(BUSINESS WIRE)--NLV Partners General Partner Dr. Liam Ratcliffe joins Array BioPharma Board of Directors as independent director.

April 30, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Israel tops the list of countries in medical device patents per capita and is fourth worldwide for biotechnology patents per capita

April 30, 2012

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Deutsche Bank 37th Annual Health Care Conference in Boston on Monday, May 7, 2012. José E. Almeida, Chairman, President...

April 30, 2012

SAN DIEGO--(BUSINESS WIRE)--Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX), a specialty pharmaceutical company, today announced that it will release its first quarter ended March 31, 2012 financial results on Thursday, May 10, 2012 before the open...

April 30, 2012

BETHESDA, Md.--(BUSINESS WIRE)--GE Capital, Healthcare Financial Services announced today that it was sole lender and administrative agent on $7.5 million in senior secured credit facilities for PharmAthene, consisting of a $2.5 million term loan...

April 30, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (NASDAQ: ARRY) announced that it has elected Liam Ratcliffe, M.D., Ph.D., to its Board of Directors as an independent director. Dr. Ratcliffe has extensive background in drug development and...

April 30, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) will present at the 37th Annual Deutsche Bank Health Care Conference on Tuesday, May 8, in Boston. John Heinmiller, executive vice president and chief financial officer, will...

April 30, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent...

April 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will webcast its presentation at the Deutsche Bank 37th Annual Health Care Conference in Boston. Harvey J. Berger, M.D., chairman and chief...

April 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus completed enrollment in the SYNERGY trial, a Phase 2b clinical trial designed to evaluate Synavive® in patients with rheumatoid arthritis (RA)

April 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) announced today that Dr. Walter C. Herlihy, President and Chief Executive Officer of Repligen, will host a conference call and webcast on Thursday, May 3, 2012 at 8:30 a.m. EDT....

April 30, 2012

NES ZIONA, Israel--(BUSINESS WIRE)--Kadimastem announced the signing of a five year framework agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany.

April 30, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda, a Westchester-based biopharma developing therapies to improve the lives of people living with MS, SCI, and other nervous system disorders, named one of the best companies to work for in NY.

April 30, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Pharmaceuticals, Inc. (Nasdaq: AVEO) today announced that the company’s management will present a company overview at upcoming investment conferences. Tuan Ha-Ngoc, president and chief executive officer, is...

April 30, 2012

NEW YORK--(BUSINESS WIRE)--Tonix Pharmaceuticals will be appearing at three upcoming investor conferences during the month of May.

April 30, 2012

NOKOMIS, Fla. & SUNNYVALE, Calif.--(BUSINESS WIRE)--Rainbow Biosciences, LLC Enters into Letter of Intent with Amarantus BioSciences to Advance Parkinson’s Disease Program

April 30, 2012

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: BioInvent International AB (publ) (OMXS:BINV) today announced that the company’s total number of shares as per 30 April 2012 amounts to 73,925,782 shares, corresponding to an equal number of votes....

April 29, 2012

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Announces 10:00 a.m. ET Conference Call and Webcast on Monday, April 30 to Discuss Agreement to Sell Blood Product Lines

April 29, 2012

--(BUSINESS WIRE)--The National Bioeconomy Blueprint, released by the White House, will be discussed by industry executives and agency leaders at BIO's World Congress on Industrial Biotechnology held in Orlando.

April 29, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US and Non-UK Healthcare Media Only New data show that TWYNSTA®, a once daily, single pill combination of the angiotensin II receptor blocker (ARB) telmisartan and the calcium channel blocker (CCB)...

April 27, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. District Court for the District of New Jersey has ruled in Merck's favor in two jointly related patent...

April 27, 2012

WASHINGTON--(BUSINESS WIRE)--Reps. Bill Pascrell (D-NJ) and Brian Bilbray (R-CA) introduced legislation granting renewable chemical companies a production tax credit

April 27, 2012

WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. announced today that it will be participating in the Goldman Sachs Leveraged Finance Healthcare Conference in New York, New York on May 1, 2012 at 2:00 p.m. Eastern Time. A link to the presentation will...

April 27, 2012

--(BUSINESS WIRE)--The community is invited to attend the 9th Annual Celebration of Biotechnology on Thursday, May 10 from 9:30 a.m. until 1 p.m. on the RTI Biologics campus in Progress Corporate Park, Alachua, Fla.

April 27, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo announced that it has been notified by the ICC that the anticipated date of the arbitration decision in its demand for arbitration has been extended from April 30 to May 31.

April 27, 2012

--(BUSINESS WIRE)--The National Bioeconomy Blueprint, released by the White House, will be discussed by industry executives and agency leaders at BIO's World Congress on Industrial Biotechnology held in Orlando.

April 27, 2012

MADISON, Wis.--(BUSINESS WIRE)--Stratatech Corp. announced positive preliminary results from the ongoing clinical trial of its StrataGraft human skin substitute.

April 27, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, announced today that the Tech Council of Maryland (TCM) has...

April 27, 2012

MINNEAPOLIS & LONDON--(BUSINESS WIRE)--Medtronic, Inc., (NYSE: MDT), announced today six month pooled outcomes from randomized and crossover patients in the Symplicity HTN-2 clinical trial following renal denervation with the Symplicity™...

April 27, 2012

MADRID & SINGAPORE--(BUSINESS WIRE)--FAES FARMA, a leading Spanish pharmaceutical group dedicated to research, development, manufacturing and marketing of pharmaceuticals, and INVIDA Holdings Private Limited, a Member of the MENARINI Group...

April 27, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics schedules first quarter 2012 financial results and conference call for May 8, 2012.

April 27, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) invites investors and the general public to listen to a webcast of its annual meeting of stockholders at 10 a.m. (ET) on Tuesday, May 1, 2012. In addition to the items being...

April 27, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter presented Phase III clinical data evaluating the safety and efficacy of GAMMAGARD LIQUID for the treatment of MMN during the American Academy of Neurology Annual Meeting in New Orleans.

April 27, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that its Annual Meeting of Stockholders will be webcast live beginning May 1, 2012 at 9:00 a.m. Eastern Daylight Time via the...

April 27, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it will report its first quarter 2012 financial results on Thursday, May 3, 2012 at approximately 4:30 p.m. ET. The press release will be followed by...

April 27, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, announced today the release of Version 8.0 of...

April 27, 2012

NEWARK, Del.--(BUSINESS WIRE)--Delaware Bio hosted its 2012 Annual Awards Gala, where over 300 academic, government, and industry leaders gathered to celebrate Incyte and 3 individuals who made significant contributions in Delaware

April 27, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks has been ranked #2 Powerhouse Company as part of the 2012 Pacesetters program by the Boston Business Journal.

April 27, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex (STO:ALNX) sells its holding in Pharmacolog i Uppsala AB to some of the other owners in the company for sek 300.000 Pharmacolog is a company that develop systems to control content and...

April 27, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE Amex: NAVB) First Quarter 2012 Earnings and Business Update Conference Call Invitation: Conference Call Scheduled for 8:30 AM EDT, Thursday, May 3rd

April 27, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today reported financial results for...

April 27, 2012

LUND, Sweden & MUNICH--(BUSINESS WIRE)--Night dialysis treatment improves both health and quality of life – new shifts across Europe Diaverum, one of the world’s leading renal care service providers, is further expanding its service portfolio...